Mast cell interactions with the nervous system: Relationship to mechanisms of disease

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 6, 1997, Pages 627-640

  Dines, Kevin C ^a   Powell, Henry C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Demyelination; Hyperglycemia; Inflammation; Mast cells; Multiple sclerosis; Nervous system

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; ESTRADIOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 3; MYELIN BASIC PROTEIN; NERVE GROWTH FACTOR; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; DEMYELINATING DISEASE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; HYPERALGESIA; HYPERGLYCEMIA; INFLAMMATORY DISEASE; INTERSTITIAL CYSTITIS; MAST CELL; MOUSE; MULTIPLE SCLEROSIS; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW;

EID: 0030834443     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199706000-00001     Document Type: Review

References (95)

1. Barrett KE, Pearce FL. Immunopharmacology of mast cells and basophils. In: Foreman JC, ed. The handbook of immunopharmacology. Academic Press Limited, 1993:29-42
2. Johnson D, Krenger W. Interactions of mast cells with the nervous system - recent advances. Neurochem Res 1992;17:939-51
3. Olsson Y. Mast cells in the nervous system. Int Rev Cytol 1968;24: 27-70
4. Krüger PG, Bø L, Myhr KM, et al. Mast cells and multiple sclerosis: A light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol Scand 1990;81:31-36
5. Theoharides TC, Sant GR, El-Mansoury M, Letourneau R, Ucci Jr. AA, Meares Jr. EM. Activation of bladder mast cells in interstitial cystitis: A light and electron microscopic study. J Urol 1995;153: 629-36
6. Dvorak AM, McLeod RS, Onderdonk AB, et al. Human gut mucosal mast cells: Ultrastructural observations and anatomic variation in mast cell-nerve associations in vivo. Int Arch Allergy Immunol 1992;98:158-68
7. Chakravarty N. Regeneration of rat mast cells after histamine secretion: Changes in histidine decarboxylase activity and heparin synthesis. Acta Pharmacologica et Toxicologica 1983;52:281-86
8. Vliagoftis H, Dimitriadou V, Boucher W, et al. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int Arch Allergy Immunol 1992;98:398-409
9. Knorr-Held S, Meier C. Mast cells in human polyneuropathies: Their density and regional distribution. Clin Neuropathol 1990;9: 121-24
10. Amann R, Schuligoi R, Herzeg G, Donnerer J. Intraplantar injection of nerve growth factor into the rat hind paw: Local edema and effects on thermal nociceptive threshold. Pain 1996;64:323-29
11. Pang X, Boucher W, Triadafilopoulos G, Sant GR, Theoharides TC. Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology 1996;47:436-38
12. Christmas TJ, Rode J, Chapple CR, Milroy EJG, Turner-Warwick RT. Nerve fibre proliferation in interstitial cystitis. Virchows Arch (A Pathol Anat) 1990;416:447-51
13. Boucher W, El-Mansoury M, Pang X, Sant GR, Theoharides TC. Elevated mast cell tryptase in the urine of patients with interstitial cystitis. Br J Urol 1995;76:94-100
14. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store and release nerve growth factor. Proc Natl Acad Sci USA 1994;91: 3739-43
15. Wiesner-Menzel L, Schulz B, Vakilzadeh F, Czarnetzki BM. Electron microscopical evidence for a direct contact between nerve fibres and mast cells. Acta Derm Venereol 1981;61:465-69
16. Coyle DE, Sehlhorst CS, Behbehani MM. Intact female rats are more susceptible to the development of tactile allodynia than ovariectomized rats following partial sciatic nerve ligation (PSNL). Neurosci Lett 1996;203:37-40
17. Frye CA, Bock BC, Kanarek RB. Hormonal milieu affects tailflick latency in female rats and may be attenuated by access to sucrose. Physiol Behav 1992:52:699-706
18. Martinez-Gómez M, Cruz Y, Salas M, Hudson R, Pacheco P. Assessing pain threshold in the rat: Changes with estrus and time of day. Physiol Behav 1994;55:651-57
19. Letourneau R, Pang X, Sant GR, Theoharides TC. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 1996;77:41-54
20. Silverman AJ, Millar RP, King JA, Zhuang X, Silver R. Mast cells with gonadotropin-releasing hormone-like immunoreactivity in the brain of doves. Proc Natl Acad Sci USA 1994;91:3695-99
21. Aloe L, Levi-Montalcini R. Mast cells increase in tissue of neonatal rats injected with nerve growth factor. Brain Res 1977;133:358-66
22. Aloe L, Probert L, Kollias G, Micera A, Tirassa P. Effect of NGF antibodies on mast cell distribution, histamine and substance P levels in the knee joint of TNF-arthritic transgenic mice. Rheumatol Int 1995;14:249-52
23. Albers KM, Wright DE, Davis BM. Overexpression of nerve growth factor in epidermis of transgenic mice causes hypertrophy of the peripheral nervous system. J Neurosci 1994;14:1422-32
24. Woolf CJ, Ma Q-P, Allchorne A, Poole S. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 1996;16:2716-23
25. Aloe L. The effects of nerve growth factor and its antibody on mast cells in vivo. J Neuroimmunol 1988;18:1-12
26. d mast cell-deficient mice. J Immunol 1983;131:2687-94
27. Orr EL. Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis. Ann NY Acad Sci 1988;540:723-26
28. Olsson Y. Mast cells in plaques of multiple sclerosis. Acta Neurol Scand 1974;50:611-18
29. Toms R, Weiner HL, Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J Neuroimmunol 1990;30:169-77
30. Ibrahim MZM, Reder AT, Lawand R, Takash W, Sallouh-Khatib S. The mast cells of the multiple sclerosis brain. J Neuroimmunol 1996;70:131-38
31. Tuomisto L, Kilpeläinen H, Riekkinen P. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 1983;13:255-57
32. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87:949-54
33. Sharief MK, Thompson EJ. In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 1992;38:27-33
34. Micera A, de Simone R, Aloe L. Elevated levels of nerve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis. Arch Ital Biol 1995;133:131-42
35. Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol 1995;37:63-66
36. Navikas V, Link H. Review: Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996;45:322-33
37. 2 can stimulate mast cell degranulation. Brain Res 1988;444:195-98
38. Watson SL, Westland K, Pollard JD. An electrophysiological and histological study of trypsin induced demyelination. J Neurol Sci 1994;126:116-25
39. Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A, McFarland HF, Raine CS. Gender differences in autoimmune demyelination in the mouse: Implications for multiple sclerosis. Ann Neurol 1996;39:724-33
40. Chiang C-S, Powell HC, Gold LH, Samimi A, Campbell IL. Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest 1996;97:1512-24
41. Bischoff SC, de Weck AL, Dahinden CA. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci USA 1990;87:6813-17
42. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993;177: 605-11
43. Powell HC, Campbell IL. Mast cell changes in opthalmic and white matter lesions associated with overexpression of interleukin-3 in transgenic mice. Brain Pathol 1996;6(3):356
44. Levin LA, Albert DM, Johnson D. Mast cells in human optic nerve. Invest Ophthalmol Vis Sci 1993;34:3147-53
45. Nelson LM, Franklin GM, Jones MC and the Multiple Sclerosis Study Group. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 1988;259:3441-43
46. Theoharides TC, Dimitriadou V, Letourneau R, Rozniecki JJ, Vliagoftis H, Boucher W. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience 1993;57: 861-71
47. Whitaker JN, Mitchell GW. A possible role for altered myelin basic protein in multiple sclerosis. Ann Neurol 1996;40:3-4
48. Whitaker JN, Kachelhofer RD, Bradley EL, et al. Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis. Ann Neurol 1995;38:625-32
49. Brenner T, Soffer D, Shalit M, Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: Characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J Neurol Sci 1994;122:210-13
50. Skaper SD, Facci L, Romanello S, Leon A. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem 1996;66:1157-66
51. Stanley NC, Jackson FL, Orr EL. Attenuation of experimental autoimmune encephalomyelitis by Compound 48/80 in Lewis rats. J Neuroimmunol 1990;29:223-28
52. Powell HC, Braheny SL, Myers RR, Rodriguez M, Lampert PW. Early changes in experimental allergic neuritis. Lab Invest 1983;48: 332-38
53. Hafer-Macko CE, Sheikh KA, Li CY et al. Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 1996;39:625-35
54. Brosnan CF, Lyman WD, Tansey FA, Carter TH. Quantitation of mast cells in experimental allergic neuritis. J Neuropathol Exp Neurol 1985;44:196-203
55. Dackiw APB, Nathens AB, Ribeiro MB, Cheung PYC, Marshall JC, Rotstein OD. Mast cell modulation of macrophage procoagulant activity and TNF production. J Surg Res 1995;59:1-5
56. Créange A, Bélec L, Clair B, Raphaël JC, Gherardi RK. Circulating tumor necrosis factor (TNF)-α and soluble TNF-α receptors in patients with Guillain-Barré syndrome. J Neuroimmunol 1996;68:95-99
57. Suzuki N, Horiuchi T, Ohta K, et al. Mast cells are essential for the full development of silica-induced pulmonary inflammation: A study with mast cell-deficient mice. Am J Respir Cell Mol Biol 1993;9:475-83
58. Brosnan CF, Bornstein MB, Bloom BR. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J Immunol 1981;126:614-20
59. Edwards RE, Wagner MMF, Moncrieff CB. Cell population and histochemistry of asbestos related lesions of rat pleural cavity after injection of various inorganic dusts. Br J Industrial Medicine 1984;41:506-13
60. 1-antitrypsin deficiency. Arch Neurol 1990;47:233-35
61. McCombe PA, Clark P, Frith JA, et al. α-1 antitrypsin phenotypes in demyelinating disease: An association between demyelinating disease and the allele PiM3. Ann Neurol 1985;18:514-16
62. 1-antitrypsin in cerebrospinal fluid of patients with neurologic diseases. Arch Neurol 1985;42:775-77
63. Inuzuka T, Sato S, Baba H, Miyatake T. Neutral proteases in cerebrospinal fluid from patients with multiple sclerosis and other neurological diseases. Acta Neurol Scand 1987;76:18-23
64. Gijbels K, Proost P, Masure S, Carton H, Billiau A, Opdenakker G. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 1993;36:432-40
65. 2macroglobulin. Acta Neurol Scand 1985;71:199-205
66. Seeldrayers PA, Yasui D, Weiner HL, Johnson D. Treatment of experimental allergic neuritis with nedocromil sodium. J Neuroimmunol 1989;25:221-26
67. Schabet M, Whitaker JN, Schott K, et al. The use of protease inhibitors in experimental allergic neuritis. J Neuroimmunol 1991;31: 265-72
68. Hewson AK, Smith T, Leonard JP, Cuzner ML. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm Res 1995;44:345-49
69. 4) plasma levels in multiple sclerosis. Acta Neurol Scand 1987;76:79-85
70. de Groot CJA, Ruuls SR, Theeuwes JWM, Dijkstra CD, van der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997;56:10-20
71. Harvey GK, Toyka KV, Hartung H-P. Effects of mast cell degranulation on blood-nerve barrier permeability and nerve conduction in vivo. J Neurol Sci 1994;125:102-9
72. Zochodne DW, Nguyen C, Sharkey KA. Accumulation and degranulation of mast cells in experimental neuromas. Neurosci Lett 1994;182:3-6
73. Kalichman MW, Powell HC, Calcutt NA, Mizisin AP. Mast cell degranulation and blood-nerve barrier permeability in rat sciatic nerve after 7 days of hyperglycemia. Am J Physiol 1995;268: H740-48
74. Brett FM, Kalichman MW, Calcutt NA, Mizisin AP. Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve. J Neurol Sci 1996;141:6-12
75. Powell HC, Moorhouse DF, Mizisin AP. A comparative ultrastructural study of Schwann cell abnormalities in human diabetic and galactose neuropathies. Brain Pathol 1994;4:562
76. Powell HC, Myers RR, Costello ML. Increased endoneurial fluid pressure following injection of histamine and compound 48/80 into rat peripheral nerves. Lab Invest 1980;43:564-72
77. 2A receptors on cultured rat schwann cells. Glia 1996;17:15-27
78. Sharma SC, Gulati OP. Role of calcium in the histamine release induced by D-galactosamine from rat mast cells. Experientia 1985;41:1177-78
79. Langlais PJ, Zhang SX, Weilersbacher G, Hough LB, Barke KE. Histamine-mediated neuronal death in a rat model of Wernicke's encephalopathy. J Neurosci Res 1994;38:565-74
80. Greenberg G, Burnstock G. A novel cell-to-cell interaction between mast cells and other types. Exp Cell Res 1983;147:1-13
81. Sanguinetti C, Greco F, de Palma L, Specchia N, Toesca A, Nori S. The ultrastructure of peripheral neurofibroma: The role of mast cells and their interaction with perineurial cells. Ital J Orthop Traumatol 1992;18:207-16
82. Keith IM, Jin J, Saban R. Nerve-mast cell interaction in normal guinea-pig urinary bladder. J Comp Neurol 1995;363:28-36
83. Theoharides TC, Spanos C, Pang X et al. Stress-induced intracranial mast cell degranulation: A corticotropin-releasing hormone-mediated effect. Endocrinology 1995;136:5745-50
84. Blennerhassett MG, Tomioka M, Bienenstock J. Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res 1991;265:121-28
85. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989;97:575-85
86. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunol Today 1994;15:533-38
87. Stead RH, Kosecka-Janiszewska U, Oestriecher AB, Dixon MF, Bienenstock J. Remodeling of B-50 (GAP-43)- and NSE-immunoreactive mucosal nerves in the intestines of rats infected with Nippostrongylus brasiliensis. J Neurosci 1991;11:3809-21
88. Meininger C. Mast cells and tumor-associated angiogenesis. Chemical Immunology. Human basophils and mast cells: Clinical aspects. Marone G, ed. Basel, Karger 1995;62:238-57
89. Norrby K, Jakobsson A, Sörbo J. Mast-cell-mediated angiogenesis: A novel experimental model using the rat mesentery. Virchows Arch [Cell Pathol] 1986;52:196-206
90. Norrby K, Jakobsson A, Simonsen M, Sörbo J. Increased angiogenesis in diabetes. Experientia 1990;46:856-60
91. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metabolism Reviews 1994;10:189-224
92. Dines KC, Cotter MA, Cameron NE. Nerve function in galactosaemic rats: Effects of evening primrose oil and doxazosin. Eur J Pharmacol 1995;281:303-9
93. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 1992;89:8150-54
94. Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mast-cell migration. Blood 1995;86:2488-93
95. Bissonnette EY, Enciso JA, Befus AD. Inhibition of tumour necrosis factor-alpha (TNF-α) release from mast cells by the antiinflammatory drugs, sodium cromoglycate and nedocromil sodium. Clin Exp Immunol 1995;102:78-84